Moderna, Inc. (0QF.F)

EUR 37.5

(-3.85%)

Operating Expenses Summary of Moderna, Inc.

Moderna, Inc.'s latest annual operating expenses in 2023 was 6.3 Billion USD , up 42.31% from previous year.
Moderna, Inc.'s latest quarterly operating expenses in 2024 Q2 was 1.46 Billion USD , up 9.87% from previous quarter.
Moderna, Inc. reported a annual operating expenses of 4.42 Billion USD in annual operating expenses 2022, up 142.84% from previous year.
Moderna, Inc. reported a annual operating expenses of 1.82 Billion USD in annual operating expenses 2021, up 77.04% from previous year.
Moderna, Inc. reported a quarterly operating expenses of 1.46 Billion USD for 2024 Q2, up 9.87% from previous quarter.
Moderna, Inc. reported a quarterly operating expenses of 1.87 Billion USD for 2023 Q4, up 17.23% from previous quarter.

Annual Operating Expenses Chart of Moderna, Inc. (2023 - 2016)

Historical Annual Operating Expenses of Moderna, Inc. (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	6.3 Billion USD	42.31%
2022	4.42 Billion USD	142.84%
2021	1.82 Billion USD	77.04%
2020	1.02 Billion USD	73.42%
2019	593.75 Million USD	10.82%
2018	535.77 Million USD	20.04%
2017	446.33 Million USD	37.2%
2016	325.3 Million USD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	1.33 Billion USD	-28.81%
2024 Q2	1.46 Billion USD	9.87%
2023 Q4	1.87 Billion USD	17.23%
2023 FY	6.3 Billion USD	42.31%
2023 Q1	1.43 Billion USD	-9.46%
2023 Q2	1.48 Billion USD	3.06%
2023 Q3	1.6 Billion USD	8.24%
2022 Q3	954 Million USD	29.27%
2022 FY	4.42 Billion USD	142.84%
2022 Q2	738 Million USD	6.03%
2022 Q1	696 Million USD	18.57%
2022 Q4	1.58 Billion USD	66.25%
2021 FY	1.82 Billion USD	77.04%
2021 Q3	549 Million USD	36.23%
2021 Q1	284 Million USD	-42.8%
2021 Q2	403 Million USD	41.9%
2021 Q4	587 Million USD	6.92%
2020 FY	1.02 Billion USD	73.42%
2020 Q4	496.48 Million USD	100.73%
2020 Q3	247.33 Million USD	64.27%
2020 Q2	150.56 Million USD	11.27%
2020 Q1	135.31 Million USD	-4.1%
2019 FY	593.75 Million USD	10.82%
2019 Q1	155.94 Million USD	-16.09%
2019 Q2	153.96 Million USD	-1.27%
2019 Q3	144.19 Million USD	-6.35%
2019 Q4	141.1 Million USD	-2.14%
2018 Q3	122.48 Million USD	-0.3%
2018 Q4	185.84 Million USD	51.74%
2018 FY	535.77 Million USD	20.04%
2018 Q1	104.86 Million USD	-19.49%
2018 Q2	122.84 Million USD	17.15%
2017 Q4	130.24 Million USD	0.0%
2017 FY	446.33 Million USD	37.2%
2016 FY	325.3 Million USD	0.0%

Peer Operating Expenses Comparison of Moderna, Inc.

Name	Operating Expenses	Operating Expenses Difference
BioNTech SE	2.52 Billion EUR	-149.13%
CureVac N.V.	211.75 Million EUR	-2875.15%
Biotest Aktiengesellschaft	136.8 Million EUR	-4505.263%
Biotest Aktiengesellschaft	136.8 Million EUR	-4505.263%
BRAIN Biotech AG	24.94 Million EUR	-25159.613%
Formycon AG	23.73 Million EUR	-26445.317%
Heidelberg Pharma AG	27.81 Million EUR	-22548.93%
Medigene AG	20.54 Million EUR	-30571.86%